白细胞介素8
转移
血管生成
癌症研究
趋化因子受体
结直肠癌
趋化因子受体
受体
趋化因子
免疫监视
信号转导
生物
免疫学
医学
癌症
细胞因子
内科学
细胞生物学
肿瘤细胞
作者
Ya-Qin Bie,Wei Ge,Zhibin Yang,Xianshuo Cheng,Zefeng Zhao,Shengjie Li,Wenchao Wang,Yu Wang,Xiaofeng Zhao,Zheng-Feng Yin,Yunfeng Li
出处
期刊:Disease Markers
[Hindawi Limited]
日期:2019-11-20
卷期号:2019: 1-12
被引量:68
摘要
CXCL8 (also known as IL-8) can produce different biological effects by binding to its receptors: CXCR1, CXCR2, and the Duffy antigen receptor for chemokines (DARC). CXCL8 and its receptors are associated with the development of various tumor types, especially colorectal cancer and its liver metastases. In addition to promoting angiogenesis, proliferation, invasion, migration, and the survival of colorectal cancer (CRC) cells, CXCL8 and its receptors have also been known to induce the epithelial-mesenchymal transition (EMT) of CRC cells, to help them to escape host immunosurveillance as well as to enhance resistance to anoikis, which promotes the formation of circulating tumor cells (CTCs) and their colonization of distant organs. In this paper, we will review the established roles of CXCL8 signaling in CRC and discuss the possible strategies of targeting CXCL8 signaling for overcoming CRC drug resistance and cancer progression, including direct targeting of CXCL8/CXCR1/2 or indirect targeting through the inhibition of CXCL8-CXCR1/2 signaling.
科研通智能强力驱动
Strongly Powered by AbleSci AI